STOCK TITAN

PHI GROUP (PHIL) Financials

PHIL OTC
FY2024 annual
Revenue $5K -80.0% YoY
Net Income Not reported for FY2024
EPS (Diluted) $0.00 n/m YoY
Free Cash Flow Not reported for FY2024
Market Cap $469K as of Oct 28, 2026
Price / Sales 93.7x on $5K revenue, FY2024
Price / Earnings n/m no net income reported
Price / Book n/m negative shareholder equity, so no book multiple, Q3 FY2025

A multiple compares the market's price with a filed figure; it says what the market pays, not how the business is doing. The market capitalization is the vendor's as of Oct 28, 2026; every other figure is from the SEC filings on this page. Not financial advice.

Source SEC Filings Latest period Q3 FY2025, ended Mar 31, 2025 Reported Currency USD FYE June

Newest figures come from the filing for Q3 FY2025, filed May 20, 2025. Each column of the statement tables below links to the filing it was taken from.

PHI GROUP, INC (PHIL) reported $5K in revenue for fiscal year 2024, down 80.0% from the prior fiscal year. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 15 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings.

Rhea AI PHIL FY2024

By FY2024, reported activity had shrunk sharply while liabilities remained vastly larger than available assets.

In FY2020, the net loss of $1.32M exceeded operating cash outflow of $720K, showing accounting results and cash movement were not closely aligned. That comparison cannot be extended through FY2024 because later annual operating cash flow and net income are not reported.

FY2024 liabilities were $9.7M against current assets of only $59K, leaving a severely constrained short-term balance sheet rather than a business financed mainly by liquid resources.

Administrative overhead did not follow the contraction in activity: SG&A was $105K, or 2101.9% of revenue, while revenue fell 80.0% from FY2023 to FY2024 and SG&A changed only -0.4%.

[ NOT FINANCIAL ADVICE ]

Financial Health Signals

Financial health score not available

PHI GROUP, INC does not currently provide enough eligible data for a peer-relative financial health score, so none is published. The metrics below are current.

Key Financial Metrics

Export CSV

Earnings & Revenue

EPS (Diluted)
$0.00
YoYn/m
QoQn/m
5Y CAGRn/m

PHI GROUP, INC earned $0.00 per diluted share (EPS) in Q3 2025. The change from the same quarter a year earlier is not meaningful, because that figure was zero or negative. The change from the prior quarter is not meaningful, because that quarter’s figure was zero or negative.

Revenue

Not reported for Q3 2025.

EBITDA

Not reported for Q3 2025.

Net Income

Not reported for Q3 2025.

Cash & Balance Sheet

Cash & Debt
$77
YoY-99.8%
QoQ-75.2%
5Y CAGR-80.9%
10Y CAGR-37.7%

PHI GROUP, INC held $77 in cash as of Q3 2025; no long-term debt figure is on record for that period.

Shares Outstanding
46.87B
YoY0.0%
QoQ0.0%

PHI GROUP, INC had 46.87B shares outstanding in Q3 2025. That is unchanged from the same quarter a year earlier. It is unchanged from the prior quarter.

Free Cash Flow

Not reported for Q3 2025.

Dividends Per Share

Not reported for Q3 2025.

Margins & Returns

None of these metrics is reported for Q3 2025.

Capital Allocation

None of these metrics is reported for Q3 2025.

PHIL Income Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

PHIL quarterly income statement
MetricQ3'25FilingQ2'25FilingQ1'25FilingQ4'24FilingQ3'24FilingQ2'24FilingQ1'24FilingQ4'23Filing
RevenueN/AN/AN/AN/AN/A$5KN/AN/A
SG&A Expenses$39K+73.7%$65K-43.6%$36K-13.8%N/A$22K-62.5%$114K+405.4%$41K+221.0%N/A
Operating Income-$100Kn/m-$146Kn/m-$171Kn/mN/A-$221Kn/m-$182Kn/m-$246Kn/mN/A
Interest Expense$42K-45.7%$42K-82.4%$42K-4.4%N/A$77K-79.6%$237K+65.7%$44K-85.6%N/A
EPS (Basic)$0.00n/m$0.00n/m$0.00n/m$0.00n/m$0.00n/m$0.00n/m$0.00n/m$0.00n/m
EPS (Diluted)$0.00n/m$0.00n/m$0.00n/m$0.00n/m$0.00n/m$0.00n/m$0.00n/m$0.00n/m
Diluted Shares (Avg)45.04B+2.3%44.84B+5.1%44.56B+8.5%N/A44.03B+29.4%42.68B+29.3%41.06B+26.8%N/A

Not reported in any period shown, so not listed: Cost of Revenue, Gross Profit, R&D Expenses, EBITDA, Income Tax, Net Income.

PHIL Balance Sheet

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

PHIL quarterly balance sheet
MetricQ3'25FilingQ2'25FilingQ1'25FilingQ4'24FilingQ3'24FilingQ2'24FilingQ1'24FilingQ4'23Filing
Total Assets$33K-79.3%$40K-78.2%$67K-75.9%$91K-69.1%$157K-50.8%$183K-64.0%$278K-53.0%$294K-37.4%
Current Assets$77-99.9%$9K-94.2%$33K-86.4%$59K-77.6%$125K-55.7%$150K-68.2%$245K-55.9%$262K-39.7%
Cash & Equivalents$77-99.8%$310-98.9%$13-99.7%$303-98.5%$42K+5.9%$29K+54.5%$4K-72.9%$20K-70.9%
Short-Term Investments$0n/m$0-100.0%$0-100.0%$0-100.0%$0-100.0%$5-98.3%$5-99.1%$420-23.1%
Long-Term Investments$32K+0.1%$31K-5.8%$34K+3.0%$32K-1.2%$32K-13.8%$33K-10.5%$33K-4.8%$33K-9.8%
Total Liabilities$11.7M+28.4%$11.5M+32.0%$10.7Mn/m$9.7Mn/m$9.1M+5.7%$8.7M+18.1%-$8.3M-220.5%-$7.9Mn/m
Current Liabilities$11.7M+28.4%$11.5M+32.0%$10.7M+21.1%$9.7M+14.4%$9.1M+5.7%$8.7M+18.1%$8.8M+28.6%$8.5M+21.4%
Non-Current Liabilities$0n/m$0n/m$0n/m$0n/m$0n/m$0n/m-$17.1Mn/m-$16.4Mn/m
Total Equity-$11.6Mn/m-$11.5Mn/m-$10.6M-224.2%-$9.7M-217.4%-$8.9Mn/m-$8.5Mn/m$8.5Mn/m$8.2M+25.7%
Retained Earnings-$88.0Mn/m-$87.5Mn/m-$86.6Mn/m-$85.5Mn/m-$83.7Mn/m-$82.0Mn/m-$80.3Mn/m-$77.3Mn/m

Not reported in any period shown, so not listed: Inventory, Accounts Receivable, Goodwill, Long-Term Debt.

PHIL Cash Flow Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

PHIL quarterly cash flow statement
MetricQ3'25FilingQ2'25FilingQ1'25FilingQ4'24FilingQ3'24FilingQ2'24FilingQ1'24FilingQ4'23Filing
Operating Cash FlowN/AN/AN/AN/AN/A-$885Kn/m-$622Kn/m-$215Kn/m
Financing Cash FlowN/AN/AN/AN/AN/A$911K+110.0%$606K+71.7%$192K+58.2%

Not reported in any period shown, so not listed: Depreciation & Amortization, Stock-Based Compensation, Capital Expenditures, Free Cash Flow, Investing Cash Flow, Dividends Paid, Share Buybacks.

PHIL Financial Ratios

Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

PHIL quarterly financial ratios
MetricQ3'25FilingQ2'25FilingQ1'25FilingQ4'24FilingQ3'24FilingQ2'24FilingQ1'24FilingQ4'23Filing
Operating MarginN/AN/AN/AN/AN/A-3633.8%N/AN/A
Current Ratio0.000.0x0.000.0x0.000.0x0.010.0x0.010.0x0.020.0x0.03-0.1x0.030.0x
Asset TurnoverN/AN/AN/AN/AN/A0.03N/AN/A

Not reported in any period shown, so not listed: Gross Margin, Net Margin, Return on Equity, Return on Assets, Debt-to-Equity, Liabilities-to-Equity, FCF Margin.

Reported as filed but not readable as a share of revenue in the periods where the ratio runs further from zero than a revenue base allows; no change figure is given where either compared period is one of those: Operating Margin.

Note: Shareholder equity is negative (-$9.7M), which causes the debt-to-equity, liabilities-to-equity and return on equity ratios to appear negative or not meaningful. This can occur from accumulated losses or large share buyback programs.

Note: The current ratio is below 1.0 (0.01), indicating current liabilities exceed current assets, which may suggest potential short-term liquidity concerns.

Frequently Asked Questions

What is PHI GROUP, INC's annual revenue?

PHI GROUP, INC (PHIL) reported $5K in total revenue for fiscal year 2024. This represents a -80.0% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

How fast is PHI GROUP, INC's revenue growing?

PHI GROUP, INC (PHIL) revenue declined by 80.0% year-over-year, from $25K to $5K in fiscal year 2024.

What is PHI GROUP, INC's earnings per share (EPS)?

PHI GROUP, INC (PHIL) reported diluted earnings per share of $0.00 for fiscal year 2024. The change from the previous fiscal year is not meaningful, because that year’s figure was zero or negative. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

PHI GROUP, INC (PHIL) had $91K in total assets as of fiscal year 2024, including both current and long-term assets.

PHI GROUP, INC (PHIL) had 46.87B shares outstanding as of fiscal year 2024.

PHI GROUP, INC (PHIL) had a current ratio of 0.01 as of fiscal year 2024, which is below 1.0, which may suggest potential liquidity concerns.

PHI GROUP, INC (PHIL) has no price-to-earnings ratio at the moment: no net income reported. The market capitalization is $469K as of Oct 28, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.

PHI GROUP, INC (PHIL) trades at 93.7x sales, its market capitalization divided by $5K revenue, FY2024. The market capitalization is $469K as of Oct 28, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.

PHI GROUP, INC (PHIL) has negative shareholder equity of -$9.7M as of fiscal year 2024, so no debt-to-equity or liabilities-to-equity ratio is reported: dividing debt by equity that is not positive produces a number that cannot be read as leverage. This can occur when accumulated losses exceed invested capital, or after large share buyback programs. Other solvency metrics like the current ratio or interest coverage may be more informative.

Back to top